Relay Therapeutics Receives Buy Rating from HC Wainwright
RLAY Stock | USD 3.00 0.05 1.69% |
Slightly above 59% of all Relay Therapeutics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Relay Therapeutics suggests that some traders are interested. Relay Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Relay Therapeutics' earnings reports, geopolitical events, and overall market trends.
Relay Therapeutics s stock had its buy rating reiterated by investment analysts at HC Wainwright in a research report issued to clients and investors on Monday, Benzinga reports. They currently have a 19.00 price objective on the stock. HC Wainwrights target price would indicate a potential upside of 179.41 percent from the
Read at thelincolnianonline.com
![]() |
Relay Therapeutics Current Investor Sentiment
Comfort Level 59
Interested
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Relay Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Relay Therapeutics.
News SentimentBullish | Hype SentimentNeutral | Insider SentimentDisposing |
Relay Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Relay Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Relay Therapeutics Historical Investor Sentiment
Investor biases related to Relay Therapeutics' public news can be used to forecast risks associated with an investment in Relay. The trend in average sentiment can be used to explain how an investor holding Relay can time the market purely based on public headlines and social activities around Relay Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Relay Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Relay Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Relay Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Relay Therapeutics.
Relay Therapeutics Fundamental Analysis
We analyze Relay Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Relay Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Relay Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Short Ratio
Short Ratio Comparative Analysis
Relay Therapeutics is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Relay Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Relay Therapeutics stock to make a market-neutral strategy. Peer analysis of Relay Therapeutics could also be used in its relative valuation, which is a method of valuing Relay Therapeutics by comparing valuation metrics with similar companies.
Peers
Relay Therapeutics Related Equities
IPSC | Century Therapeutics | 3.85 | ||||
STOK | Stoke Therapeutics | 3.43 | ||||
TERN | Terns Pharmaceuticals | 1.33 | ||||
AMLX | Amylyx Pharmaceuticals | 0.66 | ||||
EWTX | Edgewise Therapeutics | 0.82 | ||||
NRIX | Nurix Therapeutics | 1.45 | ||||
BPMC | Blueprint Medicines | 1.61 | ||||
APLS | Apellis Pharmaceuticals | 2.86 | ||||
ARVN | Arvinas | 2.94 | ||||
BDTX | Black Diamond | 2.96 | ||||
CGEM | Cullinan Oncology | 2.96 | ||||
GLUE | Monte Rosa | 3.08 | ||||
PLRX | Pliant Therapeutics | 3.42 | ||||
CCCC | C4 Therapeutics | 4.55 | ||||
DAWN | Day One | 4.59 | ||||
MLYS | Mineralys Therapeutics, | 6.15 | ||||
FHTX | Foghorn Therapeutics | 7.28 |
Additional Tools for Relay Stock Analysis
When running Relay Therapeutics' price analysis, check to measure Relay Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relay Therapeutics is operating at the current time. Most of Relay Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relay Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relay Therapeutics' price. Additionally, you may evaluate how the addition of Relay Therapeutics to your portfolios can decrease your overall portfolio volatility.